During the past decade, Baylor College of Medicine - Texas Children's Liver Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baylor College of Medicine - Texas Children's Liver Center" are "PFIC1" (1 trials), "PFIC2" (1 trials) and "Progressive Familial Intrahepatic Cholestasis" (1 trials). Many other conditions were trialed in "Baylor College of Medicine - Texas Children's Liver Center" in a lesser frequency.

Most popular intervention types in "Baylor College of Medicine - Texas Children's Liver Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "A4250 (odevixibat)" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor College of Medicine - Texas Children's Liver Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Baylor College of Medicine - Texas Children's Liver Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Baylor College of Medicine - Texas Children's Liver Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor College of Medicine - Texas Children's Liver Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".